Novavax Aktie
WKN: 898527 / ISIN: US6700021040
26.02.2015 23:06:29
|
Novavax Q4 Loss Widens
(RTTNews) - Clinical-stage vaccine company Novavax, Inc., (NVAX) reported a net loss of $31.5 million or $0.13 per share for the fourth quarter, compared to a net loss of $14.1 million or $0.07 per share for the year-ago quarter.
Revenue for the fourth quarter fell 23% to $6.7 million from $8.7 million a year earlier.
Analysts polled by Thomson Reuters expected the company to report a loss of $0.08 per share on revenue of $9.60 million for the fourth quarter.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Novavax Inc.mehr Nachrichten
Keine Nachrichten verfügbar. |